US Stock MarketDetailed Quotes

ICCM Icecure Medical

Watchlist
  • 1.070
  • +0.130+13.83%
Close Dec 13 16:00 ET
  • 1.100
  • +0.030+2.80%
Post 16:59 ET
59.39MMarket Cap-3.82P/E (TTM)

Icecure Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
102.45%662K
7.90%1.01M
4.65%743K
4.67%3.23M
33.65%1.26M
-48.42%327K
22.48%937K
-4.95%710K
-25.45%3.09M
-32.15%939K
Operating revenue
102.45%662K
7.90%1.01M
4.65%743K
4.67%3.23M
33.65%1.26M
-48.42%327K
22.48%937K
-4.95%710K
-25.45%3.09M
-32.15%939K
Cost of revenue
22.00%427K
-4.37%481K
21.54%474K
17.62%1.93M
43.51%686K
-25.21%350K
32.02%503K
24.60%390K
-15.59%1.64M
-35.49%478K
Gross profit
1,121.74%235K
22.12%530K
-15.94%269K
-10.03%1.3M
23.43%569K
-113.86%-23K
13.02%434K
-26.27%320K
-34.17%1.45M
-28.30%461K
Operating expense
10.44%4.53M
-16.77%3.76M
-8.37%3.92M
-7.19%16.88M
-9.31%3.98M
-3.91%4.1M
-3.22%4.52M
-11.98%4.28M
52.56%18.18M
16.49%4.39M
Selling and administrative expenses
40.16%2.66M
-10.80%2.17M
-9.14%1.97M
-5.05%8.6M
-2.55%2.1M
-6.40%1.9M
1.08%2.44M
-12.13%2.17M
49.97%9.06M
-0.65%2.16M
-Selling and marketing expense
77.88%1.75M
6.79%1.26M
-3.44%1.04M
16.55%1.21M
-68.72%-2.02M
39.15%981K
49.87%1.18M
43.91%1.08M
56.01%1.04M
-117.60%-1.2M
-General and administrative expense
-0.11%918K
-27.27%915K
-14.76%930K
-7.85%7.39M
22.92%4.12M
-30.64%919K
-22.54%1.26M
-36.50%1.09M
49.22%8.02M
23.30%3.36M
Research and development costs
-15.23%1.87M
-23.76%1.59M
-7.58%1.95M
-9.32%8.27M
-15.82%1.88M
-1.65%2.2M
-7.80%2.08M
-11.82%2.11M
55.23%9.12M
39.73%2.24M
Operating profit
-4.12%-4.29M
20.90%-3.23M
7.76%-3.65M
6.95%-15.58M
13.15%-3.42M
-0.54%-4.12M
4.67%-4.08M
10.58%-3.96M
-72.14%-16.74M
-25.70%-3.93M
Net non-operating interest income expense
17.07%144K
-23.44%147K
-78.31%41K
486.61%924K
2,200.00%420K
186.05%123K
180.00%192K
959.09%189K
-39.77%-239K
37.50%-20K
Total other finance cost
----
----
78.31%-41K
-486.61%-924K
-2,200.00%-420K
----
----
-959.09%-189K
39.77%239K
--20K
Other net income (expense)
Income before tax
-3.73%-4.15M
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
Income tax
Net income
-3.73%-4.15M
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
Net income continuous Operations
-3.73%-4.15M
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
Minority interest income
Net income attributable to the parent company
-3.73%-4.15M
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-3.73%-4.15M
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
Basic earnings per share
11.11%-0.08
33.33%-0.06
0.00%-0.08
30.43%-0.32
43.40%-0.06
18.18%-0.09
27.42%-0.09
33.33%-0.08
-31.43%-0.46
-4.95%-0.106
Diluted earnings per share
11.11%-0.08
33.33%-0.06
0.00%-0.08
30.43%-0.32
43.40%-0.06
18.18%-0.09
27.42%-0.09
33.33%-0.08
-31.43%-0.46
-4.95%-0.106
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 102.45%662K7.90%1.01M4.65%743K4.67%3.23M33.65%1.26M-48.42%327K22.48%937K-4.95%710K-25.45%3.09M-32.15%939K
Operating revenue 102.45%662K7.90%1.01M4.65%743K4.67%3.23M33.65%1.26M-48.42%327K22.48%937K-4.95%710K-25.45%3.09M-32.15%939K
Cost of revenue 22.00%427K-4.37%481K21.54%474K17.62%1.93M43.51%686K-25.21%350K32.02%503K24.60%390K-15.59%1.64M-35.49%478K
Gross profit 1,121.74%235K22.12%530K-15.94%269K-10.03%1.3M23.43%569K-113.86%-23K13.02%434K-26.27%320K-34.17%1.45M-28.30%461K
Operating expense 10.44%4.53M-16.77%3.76M-8.37%3.92M-7.19%16.88M-9.31%3.98M-3.91%4.1M-3.22%4.52M-11.98%4.28M52.56%18.18M16.49%4.39M
Selling and administrative expenses 40.16%2.66M-10.80%2.17M-9.14%1.97M-5.05%8.6M-2.55%2.1M-6.40%1.9M1.08%2.44M-12.13%2.17M49.97%9.06M-0.65%2.16M
-Selling and marketing expense 77.88%1.75M6.79%1.26M-3.44%1.04M16.55%1.21M-68.72%-2.02M39.15%981K49.87%1.18M43.91%1.08M56.01%1.04M-117.60%-1.2M
-General and administrative expense -0.11%918K-27.27%915K-14.76%930K-7.85%7.39M22.92%4.12M-30.64%919K-22.54%1.26M-36.50%1.09M49.22%8.02M23.30%3.36M
Research and development costs -15.23%1.87M-23.76%1.59M-7.58%1.95M-9.32%8.27M-15.82%1.88M-1.65%2.2M-7.80%2.08M-11.82%2.11M55.23%9.12M39.73%2.24M
Operating profit -4.12%-4.29M20.90%-3.23M7.76%-3.65M6.95%-15.58M13.15%-3.42M-0.54%-4.12M4.67%-4.08M10.58%-3.96M-72.14%-16.74M-25.70%-3.93M
Net non-operating interest income expense 17.07%144K-23.44%147K-78.31%41K486.61%924K2,200.00%420K186.05%123K180.00%192K959.09%189K-39.77%-239K37.50%-20K
Total other finance cost --------78.31%-41K-486.61%-924K-2,200.00%-420K---------959.09%-189K39.77%239K--20K
Other net income (expense)
Income before tax -3.73%-4.15M20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M
Income tax
Net income -3.73%-4.15M20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M
Net income continuous Operations -3.73%-4.15M20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M
Minority interest income
Net income attributable to the parent company -3.73%-4.15M20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -3.73%-4.15M20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M
Basic earnings per share 11.11%-0.0833.33%-0.060.00%-0.0830.43%-0.3243.40%-0.0618.18%-0.0927.42%-0.0933.33%-0.08-31.43%-0.46-4.95%-0.106
Diluted earnings per share 11.11%-0.0833.33%-0.060.00%-0.0830.43%-0.3243.40%-0.0618.18%-0.0927.42%-0.0933.33%-0.08-31.43%-0.46-4.95%-0.106
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.06%